The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Molecular Diagnostic Systems-Global Market Insights and Sales Trends 2024
Synopsis
Molecular Diagnostic Systems
The global Molecular Diagnostic Systems market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Molecular Diagnostic Systems in various end use industries. The expanding demands from the Infectious Disease, Cancer and Others,, are propelling Molecular Diagnostic Systems market. Stationary, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Handheld segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Molecular Diagnostic Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Molecular Diagnostic Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Molecular Diagnostic Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Molecular Diagnostic Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Molecular Diagnostic Systems covered in this report include Siemens, Roche, Cepheid, BD, Adaltis Srl, NeuMoDx, Abbott, Hologic and Mobidiag, etc.
The global Molecular Diagnostic Systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Siemens
Roche
Cepheid
BD
Adaltis Srl
NeuMoDx
Abbott
Hologic
Mobidiag
microLIQUID
Bruker
Mesa Biotech
Global Molecular Diagnostic Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Molecular Diagnostic Systems market, Segment by Type:
Stationary
Handheld
Global Molecular Diagnostic Systems market, by Application
Infectious Disease
Cancer
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Molecular Diagnostic Systems manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Molecular Diagnostic Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Molecular Diagnostic Systems
The global Molecular Diagnostic Systems market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Molecular Diagnostic Systems in various end use industries. The expanding demands from the Infectious Disease, Cancer and Others,, are propelling Molecular Diagnostic Systems market. Stationary, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Handheld segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Molecular Diagnostic Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Molecular Diagnostic Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Molecular Diagnostic Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Molecular Diagnostic Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Molecular Diagnostic Systems covered in this report include Siemens, Roche, Cepheid, BD, Adaltis Srl, NeuMoDx, Abbott, Hologic and Mobidiag, etc.
The global Molecular Diagnostic Systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Siemens
Roche
Cepheid
BD
Adaltis Srl
NeuMoDx
Abbott
Hologic
Mobidiag
microLIQUID
Bruker
Mesa Biotech
Global Molecular Diagnostic Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Molecular Diagnostic Systems market, Segment by Type:
Stationary
Handheld
Global Molecular Diagnostic Systems market, by Application
Infectious Disease
Cancer
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Molecular Diagnostic Systems manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Molecular Diagnostic Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Molecular Diagnostic Systems Market Overview
1.1 Molecular Diagnostic Systems Product Overview
1.2 Molecular Diagnostic Systems Market Segment by Type
1.2.1 Stationary
1.2.2 Handheld
1.3 Global Molecular Diagnostic Systems Market Size by Type
1.3.1 Global Molecular Diagnostic Systems Market Size Overview by Type (2018-2029)
1.3.2 Global Molecular Diagnostic Systems Historic Market Size Review by Type (2018-2023)
1.3.3 Global Molecular Diagnostic Systems Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Molecular Diagnostic Systems Sales Breakdown by Type (2018-2023)
1.4.2 Europe Molecular Diagnostic Systems Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Molecular Diagnostic Systems Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Molecular Diagnostic Systems Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Molecular Diagnostic Systems Sales Breakdown by Type (2018-2023)
2 Global Molecular Diagnostic Systems Market Competition by Company
2.1 Global Top Players by Molecular Diagnostic Systems Sales (2018-2023)
2.2 Global Top Players by Molecular Diagnostic Systems Revenue (2018-2023)
2.3 Global Top Players by Molecular Diagnostic Systems Price (2018-2023)
2.4 Global Top Manufacturers Molecular Diagnostic Systems Manufacturing Base Distribution, Sales Area, Product Type
2.5 Molecular Diagnostic Systems Market Competitive Situation and Trends
2.5.1 Molecular Diagnostic Systems Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Molecular Diagnostic Systems Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Molecular Diagnostic Systems as of 2022)
2.7 Date of Key Manufacturers Enter into Molecular Diagnostic Systems Market
2.8 Key Manufacturers Molecular Diagnostic Systems Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Molecular Diagnostic Systems Status and Outlook by Region
3.1 Global Molecular Diagnostic Systems Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Molecular Diagnostic Systems Historic Market Size by Region
3.2.1 Global Molecular Diagnostic Systems Sales in Volume by Region (2018-2023)
3.2.2 Global Molecular Diagnostic Systems Sales in Value by Region (2018-2023)
3.2.3 Global Molecular Diagnostic Systems Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Molecular Diagnostic Systems Forecasted Market Size by Region
3.3.1 Global Molecular Diagnostic Systems Sales in Volume by Region (2024-2029)
3.3.2 Global Molecular Diagnostic Systems Sales in Value by Region (2024-2029)
3.3.3 Global Molecular Diagnostic Systems Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Molecular Diagnostic Systems by Application
4.1 Molecular Diagnostic Systems Market Segment by Application
4.1.1 Infectious Disease
4.1.2 Cancer
4.1.3 Others
4.2 Global Molecular Diagnostic Systems Market Size by Application
4.2.1 Global Molecular Diagnostic Systems Market Size Overview by Application (2018-2029)
4.2.2 Global Molecular Diagnostic Systems Historic Market Size Review by Application (2018-2023)
4.2.3 Global Molecular Diagnostic Systems Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Molecular Diagnostic Systems Sales Breakdown by Application (2018-2023)
4.3.2 Europe Molecular Diagnostic Systems Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Molecular Diagnostic Systems Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Molecular Diagnostic Systems Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Molecular Diagnostic Systems Sales Breakdown by Application (2018-2023)
5 North America Molecular Diagnostic Systems by Country
5.1 North America Molecular Diagnostic Systems Historic Market Size by Country
5.1.1 North America Molecular Diagnostic Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Molecular Diagnostic Systems Sales in Volume by Country (2018-2023)
5.1.3 North America Molecular Diagnostic Systems Sales in Value by Country (2018-2023)
5.2 North America Molecular Diagnostic Systems Forecasted Market Size by Country
5.2.1 North America Molecular Diagnostic Systems Sales in Volume by Country (2024-2029)
5.2.2 North America Molecular Diagnostic Systems Sales in Value by Country (2024-2029)
6 Europe Molecular Diagnostic Systems by Country
6.1 Europe Molecular Diagnostic Systems Historic Market Size by Country
6.1.1 Europe Molecular Diagnostic Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Molecular Diagnostic Systems Sales in Volume by Country (2018-2023)
6.1.3 Europe Molecular Diagnostic Systems Sales in Value by Country (2018-2023)
6.2 Europe Molecular Diagnostic Systems Forecasted Market Size by Country
6.2.1 Europe Molecular Diagnostic Systems Sales in Volume by Country (2024-2029)
6.2.2 Europe Molecular Diagnostic Systems Sales in Value by Country (2024-2029)
7 Asia-Pacific Molecular Diagnostic Systems by Region
7.1 Asia-Pacific Molecular Diagnostic Systems Historic Market Size by Region
7.1.1 Asia-Pacific Molecular Diagnostic Systems Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Molecular Diagnostic Systems Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Molecular Diagnostic Systems Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Molecular Diagnostic Systems Forecasted Market Size by Region
7.2.1 Asia-Pacific Molecular Diagnostic Systems Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Molecular Diagnostic Systems Sales in Value by Region (2024-2029)
8 Latin America Molecular Diagnostic Systems by Country
8.1 Latin America Molecular Diagnostic Systems Historic Market Size by Country
8.1.1 Latin America Molecular Diagnostic Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Molecular Diagnostic Systems Sales in Volume by Country (2018-2023)
8.1.3 Latin America Molecular Diagnostic Systems Sales in Value by Country (2018-2023)
8.2 Latin America Molecular Diagnostic Systems Forecasted Market Size by Country
8.2.1 Latin America Molecular Diagnostic Systems Sales in Volume by Country (2024-2029)
8.2.2 Latin America Molecular Diagnostic Systems Sales in Value by Country (2024-2029)
9 Middle East and Africa Molecular Diagnostic Systems by Country
9.1 Middle East and Africa Molecular Diagnostic Systems Historic Market Size by Country
9.1.1 Middle East and Africa Molecular Diagnostic Systems Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Molecular Diagnostic Systems Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Molecular Diagnostic Systems Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Molecular Diagnostic Systems Forecasted Market Size by Country
9.2.1 Middle East and Africa Molecular Diagnostic Systems Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Molecular Diagnostic Systems Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Siemens
10.1.1 Siemens Company Information
10.1.2 Siemens Introduction and Business Overview
10.1.3 Siemens Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Siemens Molecular Diagnostic Systems Products Offered
10.1.5 Siemens Recent Development
10.2 Roche
10.2.1 Roche Company Information
10.2.2 Roche Introduction and Business Overview
10.2.3 Roche Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Roche Molecular Diagnostic Systems Products Offered
10.2.5 Roche Recent Development
10.3 Cepheid
10.3.1 Cepheid Company Information
10.3.2 Cepheid Introduction and Business Overview
10.3.3 Cepheid Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Cepheid Molecular Diagnostic Systems Products Offered
10.3.5 Cepheid Recent Development
10.4 BD
10.4.1 BD Company Information
10.4.2 BD Introduction and Business Overview
10.4.3 BD Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2018-2023)
10.4.4 BD Molecular Diagnostic Systems Products Offered
10.4.5 BD Recent Development
10.5 Adaltis Srl
10.5.1 Adaltis Srl Company Information
10.5.2 Adaltis Srl Introduction and Business Overview
10.5.3 Adaltis Srl Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Adaltis Srl Molecular Diagnostic Systems Products Offered
10.5.5 Adaltis Srl Recent Development
10.6 NeuMoDx
10.6.1 NeuMoDx Company Information
10.6.2 NeuMoDx Introduction and Business Overview
10.6.3 NeuMoDx Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2018-2023)
10.6.4 NeuMoDx Molecular Diagnostic Systems Products Offered
10.6.5 NeuMoDx Recent Development
10.7 Abbott
10.7.1 Abbott Company Information
10.7.2 Abbott Introduction and Business Overview
10.7.3 Abbott Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Abbott Molecular Diagnostic Systems Products Offered
10.7.5 Abbott Recent Development
10.8 Hologic
10.8.1 Hologic Company Information
10.8.2 Hologic Introduction and Business Overview
10.8.3 Hologic Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Hologic Molecular Diagnostic Systems Products Offered
10.8.5 Hologic Recent Development
10.9 Mobidiag
10.9.1 Mobidiag Company Information
10.9.2 Mobidiag Introduction and Business Overview
10.9.3 Mobidiag Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Mobidiag Molecular Diagnostic Systems Products Offered
10.9.5 Mobidiag Recent Development
10.10 microLIQUID
10.10.1 microLIQUID Company Information
10.10.2 microLIQUID Introduction and Business Overview
10.10.3 microLIQUID Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2018-2023)
10.10.4 microLIQUID Molecular Diagnostic Systems Products Offered
10.10.5 microLIQUID Recent Development
10.11 Bruker
10.11.1 Bruker Company Information
10.11.2 Bruker Introduction and Business Overview
10.11.3 Bruker Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Bruker Molecular Diagnostic Systems Products Offered
10.11.5 Bruker Recent Development
10.12 Mesa Biotech
10.12.1 Mesa Biotech Company Information
10.12.2 Mesa Biotech Introduction and Business Overview
10.12.3 Mesa Biotech Molecular Diagnostic Systems Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Mesa Biotech Molecular Diagnostic Systems Products Offered
10.12.5 Mesa Biotech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Molecular Diagnostic Systems Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Molecular Diagnostic Systems Industrial Chain Analysis
11.4 Molecular Diagnostic Systems Market Dynamics
11.4.1 Molecular Diagnostic Systems Industry Trends
11.4.2 Molecular Diagnostic Systems Market Drivers
11.4.3 Molecular Diagnostic Systems Market Challenges
11.4.4 Molecular Diagnostic Systems Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Molecular Diagnostic Systems Distributors
12.3 Molecular Diagnostic Systems Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
